Joint Disease Therapeutics Market, Global Outlook and Forecast 2022-2028

March 2022 | 60 pages | ID: J1E7BFC75DA8EN
Market Monitor Global

Abstracts

Joint disease is defined as any type of injury or inflammation or disease that affects the joints of the body. Joint disease can range from acute to very chronic, excruciatingly painful or simply nagging and uncomfortable.

This report contains market size and forecasts of Joint Disease Therapeutics in Global, including the following market information:

Global Joint Disease Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Joint Disease Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Drug Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Joint Disease Therapeutics include AbbVie, Pfizer, Bristol-Myers Squibb, Roche, GlaxoSmithKline, AstraZeneca, Astellas Pharma, Johnson&Johnson and Amgen, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Joint Disease Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Joint Disease Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Joint Disease Therapeutics Market Segment Percentages, by Type, 2021 (%)

• Drug Therapy
• Rehabilitation
• Surgical Operation

Global Joint Disease Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Joint Disease Therapeutics Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinic
• Others

Global Joint Disease Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Joint Disease Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Joint Disease Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Joint Disease Therapeutics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• AbbVie
• Pfizer
• Bristol-Myers Squibb
• Roche
• GlaxoSmithKline
• AstraZeneca
• Astellas Pharma
• Johnson&Johnson
• Amgen
• Novartis
• Sanofi
• Daiiachi Sankyo

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Joint Disease Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Joint Disease Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL JOINT DISEASE THERAPEUTICS OVERALL MARKET SIZE

2.1 Global Joint Disease Therapeutics Market Size: 2021 VS 2028
2.2 Global Joint Disease Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Joint Disease Therapeutics Players in Global Market
3.2 Top Global Joint Disease Therapeutics Companies Ranked by Revenue
3.3 Global Joint Disease Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Joint Disease Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Joint Disease Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Joint Disease Therapeutics Players in Global Market
  3.6.1 List of Global Tier 1 Joint Disease Therapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Joint Disease Therapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Joint Disease Therapeutics Market Size Markets, 2021 & 2028
  4.1.2 Drug Therapy
  4.1.3 Rehabilitation
  4.1.4 Surgical Operation
4.2 By Type - Global Joint Disease Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global Joint Disease Therapeutics Revenue, 2017-2022
  4.2.2 By Type - Global Joint Disease Therapeutics Revenue, 2023-2028
  4.2.3 By Type - Global Joint Disease Therapeutics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Joint Disease Therapeutics Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Clinic
  5.1.4 Others
5.2 By Application - Global Joint Disease Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global Joint Disease Therapeutics Revenue, 2017-2022
  5.2.2 By Application - Global Joint Disease Therapeutics Revenue, 2023-2028
  5.2.3 By Application - Global Joint Disease Therapeutics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Joint Disease Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Joint Disease Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global Joint Disease Therapeutics Revenue, 2017-2022
  6.2.2 By Region - Global Joint Disease Therapeutics Revenue, 2023-2028
  6.2.3 By Region - Global Joint Disease Therapeutics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Joint Disease Therapeutics Revenue, 2017-2028
  6.3.2 US Joint Disease Therapeutics Market Size, 2017-2028
  6.3.3 Canada Joint Disease Therapeutics Market Size, 2017-2028
  6.3.4 Mexico Joint Disease Therapeutics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Joint Disease Therapeutics Revenue, 2017-2028
  6.4.2 Germany Joint Disease Therapeutics Market Size, 2017-2028
  6.4.3 France Joint Disease Therapeutics Market Size, 2017-2028
  6.4.4 U.K. Joint Disease Therapeutics Market Size, 2017-2028
  6.4.5 Italy Joint Disease Therapeutics Market Size, 2017-2028
  6.4.6 Russia Joint Disease Therapeutics Market Size, 2017-2028
  6.4.7 Nordic Countries Joint Disease Therapeutics Market Size, 2017-2028
  6.4.8 Benelux Joint Disease Therapeutics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Joint Disease Therapeutics Revenue, 2017-2028
  6.5.2 China Joint Disease Therapeutics Market Size, 2017-2028
  6.5.3 Japan Joint Disease Therapeutics Market Size, 2017-2028
  6.5.4 South Korea Joint Disease Therapeutics Market Size, 2017-2028
  6.5.5 Southeast Asia Joint Disease Therapeutics Market Size, 2017-2028
  6.5.6 India Joint Disease Therapeutics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Joint Disease Therapeutics Revenue, 2017-2028
  6.6.2 Brazil Joint Disease Therapeutics Market Size, 2017-2028
  6.6.3 Argentina Joint Disease Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Joint Disease Therapeutics Revenue, 2017-2028
  6.7.2 Turkey Joint Disease Therapeutics Market Size, 2017-2028
  6.7.3 Israel Joint Disease Therapeutics Market Size, 2017-2028
  6.7.4 Saudi Arabia Joint Disease Therapeutics Market Size, 2017-2028
  6.7.5 UAE Joint Disease Therapeutics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 AbbVie
  7.1.1 AbbVie Corporate Summary
  7.1.2 AbbVie Business Overview
  7.1.3 AbbVie Joint Disease Therapeutics Major Product Offerings
  7.1.4 AbbVie Joint Disease Therapeutics Revenue in Global Market (2017-2022)
  7.1.5 AbbVie Key News
7.2 Pfizer
  7.2.1 Pfizer Corporate Summary
  7.2.2 Pfizer Business Overview
  7.2.3 Pfizer Joint Disease Therapeutics Major Product Offerings
  7.2.4 Pfizer Joint Disease Therapeutics Revenue in Global Market (2017-2022)
  7.2.5 Pfizer Key News
7.3 Bristol-Myers Squibb
  7.3.1 Bristol-Myers Squibb Corporate Summary
  7.3.2 Bristol-Myers Squibb Business Overview
  7.3.3 Bristol-Myers Squibb Joint Disease Therapeutics Major Product Offerings
  7.3.4 Bristol-Myers Squibb Joint Disease Therapeutics Revenue in Global Market (2017-2022)
  7.3.5 Bristol-Myers Squibb Key News
7.4 Roche
  7.4.1 Roche Corporate Summary
  7.4.2 Roche Business Overview
  7.4.3 Roche Joint Disease Therapeutics Major Product Offerings
  7.4.4 Roche Joint Disease Therapeutics Revenue in Global Market (2017-2022)
  7.4.5 Roche Key News
7.5 GlaxoSmithKline
  7.5.1 GlaxoSmithKline Corporate Summary
  7.5.2 GlaxoSmithKline Business Overview
  7.5.3 GlaxoSmithKline Joint Disease Therapeutics Major Product Offerings
  7.5.4 GlaxoSmithKline Joint Disease Therapeutics Revenue in Global Market (2017-2022)
  7.5.5 GlaxoSmithKline Key News
7.6 AstraZeneca
  7.6.1 AstraZeneca Corporate Summary
  7.6.2 AstraZeneca Business Overview
  7.6.3 AstraZeneca Joint Disease Therapeutics Major Product Offerings
  7.6.4 AstraZeneca Joint Disease Therapeutics Revenue in Global Market (2017-2022)
  7.6.5 AstraZeneca Key News
7.7 Astellas Pharma
  7.7.1 Astellas Pharma Corporate Summary
  7.7.2 Astellas Pharma Business Overview
  7.7.3 Astellas Pharma Joint Disease Therapeutics Major Product Offerings
  7.7.4 Astellas Pharma Joint Disease Therapeutics Revenue in Global Market (2017-2022)
  7.7.5 Astellas Pharma Key News
7.8 Johnson&Johnson
  7.8.1 Johnson&Johnson Corporate Summary
  7.8.2 Johnson&Johnson Business Overview
  7.8.3 Johnson&Johnson Joint Disease Therapeutics Major Product Offerings
  7.8.4 Johnson&Johnson Joint Disease Therapeutics Revenue in Global Market (2017-2022)
  7.8.5 Johnson&Johnson Key News
7.9 Amgen
  7.9.1 Amgen Corporate Summary
  7.9.2 Amgen Business Overview
  7.9.3 Amgen Joint Disease Therapeutics Major Product Offerings
  7.9.4 Amgen Joint Disease Therapeutics Revenue in Global Market (2017-2022)
  7.9.5 Amgen Key News
7.10 Novartis
  7.10.1 Novartis Corporate Summary
  7.10.2 Novartis Business Overview
  7.10.3 Novartis Joint Disease Therapeutics Major Product Offerings
  7.10.4 Novartis Joint Disease Therapeutics Revenue in Global Market (2017-2022)
  7.10.5 Novartis Key News
7.11 Sanofi
  7.11.1 Sanofi Corporate Summary
  7.11.2 Sanofi Business Overview
  7.11.3 Sanofi Joint Disease Therapeutics Major Product Offerings
  7.11.4 Sanofi Joint Disease Therapeutics Revenue in Global Market (2017-2022)
  7.11.5 Sanofi Key News
7.12 Daiiachi Sankyo
  7.12.1 Daiiachi Sankyo Corporate Summary
  7.12.2 Daiiachi Sankyo Business Overview
  7.12.3 Daiiachi Sankyo Joint Disease Therapeutics Major Product Offerings
  7.12.4 Daiiachi Sankyo Joint Disease Therapeutics Revenue in Global Market (2017-2022)
  7.12.5 Daiiachi Sankyo Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Joint Disease Therapeutics Market Opportunities & Trends in Global Market
Table 2. Joint Disease Therapeutics Market Drivers in Global Market
Table 3. Joint Disease Therapeutics Market Restraints in Global Market
Table 4. Key Players of Joint Disease Therapeutics in Global Market
Table 5. Top Joint Disease Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Joint Disease Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Joint Disease Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Joint Disease Therapeutics Product Type
Table 9. List of Global Tier 1 Joint Disease Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Joint Disease Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Joint Disease Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Joint Disease Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Joint Disease Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Joint Disease Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Joint Disease Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Joint Disease Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Joint Disease Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Joint Disease Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Joint Disease Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Joint Disease Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Joint Disease Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Joint Disease Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Joint Disease Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Joint Disease Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Joint Disease Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Joint Disease Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Joint Disease Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Joint Disease Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Joint Disease Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. AbbVie Corporate Summary
Table 31. AbbVie Joint Disease Therapeutics Product Offerings
Table 32. AbbVie Joint Disease Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Pfizer Corporate Summary
Table 34. Pfizer Joint Disease Therapeutics Product Offerings
Table 35. Pfizer Joint Disease Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Bristol-Myers Squibb Corporate Summary
Table 37. Bristol-Myers Squibb Joint Disease Therapeutics Product Offerings
Table 38. Bristol-Myers Squibb Joint Disease Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Roche Corporate Summary
Table 40. Roche Joint Disease Therapeutics Product Offerings
Table 41. Roche Joint Disease Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. GlaxoSmithKline Corporate Summary
Table 43. GlaxoSmithKline Joint Disease Therapeutics Product Offerings
Table 44. GlaxoSmithKline Joint Disease Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. AstraZeneca Corporate Summary
Table 46. AstraZeneca Joint Disease Therapeutics Product Offerings
Table 47. AstraZeneca Joint Disease Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. Astellas Pharma Corporate Summary
Table 49. Astellas Pharma Joint Disease Therapeutics Product Offerings
Table 50. Astellas Pharma Joint Disease Therapeutics Revenue (US$, Mn), (2017-2022)
Table 51. Johnson&Johnson Corporate Summary
Table 52. Johnson&Johnson Joint Disease Therapeutics Product Offerings
Table 53. Johnson&Johnson Joint Disease Therapeutics Revenue (US$, Mn), (2017-2022)
Table 54. Amgen Corporate Summary
Table 55. Amgen Joint Disease Therapeutics Product Offerings
Table 56. Amgen Joint Disease Therapeutics Revenue (US$, Mn), (2017-2022)
Table 57. Novartis Corporate Summary
Table 58. Novartis Joint Disease Therapeutics Product Offerings
Table 59. Novartis Joint Disease Therapeutics Revenue (US$, Mn), (2017-2022)
Table 60. Sanofi Corporate Summary
Table 61. Sanofi Joint Disease Therapeutics Product Offerings
Table 62. Sanofi Joint Disease Therapeutics Revenue (US$, Mn), (2017-2022)
Table 63. Daiiachi Sankyo Corporate Summary
Table 64. Daiiachi Sankyo Joint Disease Therapeutics Product Offerings
Table 65. Daiiachi Sankyo Joint Disease Therapeutics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Joint Disease Therapeutics Segment by Type in 2021
Figure 2. Joint Disease Therapeutics Segment by Application in 2021
Figure 3. Global Joint Disease Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Joint Disease Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Joint Disease Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Joint Disease Therapeutics Revenue in 2021
Figure 8. By Type - Global Joint Disease Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Joint Disease Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Joint Disease Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Joint Disease Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Joint Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Joint Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Joint Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Joint Disease Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Joint Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Joint Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Joint Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Joint Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Joint Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Joint Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Joint Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Joint Disease Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Joint Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Joint Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Joint Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Joint Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Joint Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Joint Disease Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Joint Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Joint Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Joint Disease Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Joint Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Joint Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Joint Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Joint Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. AbbVie Joint Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Pfizer Joint Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Bristol-Myers Squibb Joint Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Roche Joint Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. GlaxoSmithKline Joint Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. AstraZeneca Joint Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Astellas Pharma Joint Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Johnson&Johnson Joint Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Amgen Joint Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Novartis Joint Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Sanofi Joint Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Daiiachi Sankyo Joint Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)